Advertisement

Topics

Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL Company Profile

14:12 EDT 23rd June 2018 | BioPortfolio


News Articles [2015 Associated News Articles listed on BioPortfolio]

Testosterone Replacement Therapy Does Not Raise CV Risks

A large study of middle-aged men found that testosterone replacement therapy is associated with a small but significant decrease in cardiovascular risk and an increased risk of obstructive sleep apnea...

Lipocine Craters After FDA Rejects Testosterone Replacement Therapy Drug for the Second Time

Shares of Utah-based Lipocine, Inc. are down more than 41 percent in premarket trading after the company announced it received a second Complete Response Letter from the U.S. Food and Drug Administrat...

Testosterone replacement drug rejected by FDA

US regulators have rejected Lipocine’s Tlando, a testosterone replacement therapy for adult males with hypogonadism.

VIDEO: Updated testosterone replacement guideline includes benefits, concerns of therapy

CHICAGO — In this video exclusive, Tamara Wexler, MD, PhD, neuroendocrinologist and reproductive endocrinologist, and clinical assistant professor in the department of rehabilitation medicine at NYU...

Long-term testosterone replacement fails to improve insulin sensitivity

Men with low or low-normal testosterone assigned to testosterone replacement vs. placebo did not experience improvements in insulin sensitivity, suggesting that testosterone supplementation may not be...

Lipocine Announces Outcome of FDA Advisory Committee Meeting for Tlando, Testosterone Replacement Therapy in Adult Males with Hypogonadism

SALT LAKE CITY, Utah, Jan. 10, 2018 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, today announced that the Bone, Reproductive and Urologic Drugs Advisory Committee ...

FDA turns down Lipocine’s application for oral testosterone product Tlando

The US Food and Drug Administration (FDA) has refused to approve Lipocine's Tlando, an oral testosterone product candidate for testosterone replacement therapy (TRT).

Lipocine Receives Complete Response Letter From FDA

NewsThe company has received a Complete Response Letter ("CRL") for Tlando, the Company's oral testosterone product candidate for testosterone replacement therapy ("TRT") in adult males for conditions...

Drugs and Medications [146 Associated Drugs and Medications listed on BioPortfolio]

Androgel [Abbott Products, Inc.]

These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%.AndroGel (testosterone gel) 1.62% for topic...

Socalm pain relieving [AB7 Industries ]

soCALM Back Pain Relieving Patch Medium

Socalm pain relieving [AB7 Industries ]

soCALM Wrist Pain Relieving Patch Large

Socalm pain relieving [AB7 Industries ]

soCALM Back Pain Relieving Patch Large

Socalm pain relieving [AB7 Industries ]

soCALM Elbow Pain Relieving Patch Medium

PubMed Articles [3709 Associated PubMed Articles listed on BioPortfolio]

The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: A systematic review and meta-analysis of randomized, placebo-controlled trials.

The efficacy and safety of testosterone replacement therapy (TRT) in hypogonadal men remain incompletely understood.

The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.

This study set out to assess effects of testosterone replacement therapy (TRT) on parameters of metabolic syndrome and vascular function in obese hypogonadal males with type 2 diabetes mellitus (DM2).

Addition of Estradiol to Cross-sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE -/- Mice.

The contributions of estradiol and testosterone to atherosclerotic lesion progression are not entirely understood. Cross-sex hormone therapy (XHT) for transgender individuals dramatically alters estro...

Testosterone replacement therapy and the risk of stroke in men: A systematic review.

In recent years, questions have been raised regarding the cardiovascular safety of testosterone replacement therapy (TRT). The objective of this study was to systematically review the available eviden...

Androgens mediate β-adrenergic vasorelaxation impairment via adenylyl cyclase.

Cardiovascular disease development has been associated with gender differences, suggesting that sex hormones are implicated in vascular function and development of hypertension. Vascular tone comparis...

Clinical Trials [4041 Associated Clinical Trials listed on BioPortfolio]

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

The T-001 study is a placebo-controlled investigation of the effects of injectable testosterone replacement therapy on prostate tissues of aging men with low testosterone levels. The prim...

Testosterone Therapy After Hip Fracture in Elderly Women

The purpose of this study is to determine the feasibility of testosterone replacement therapy in frail elderly female hip fracture patients who have testosterone deficiency, and to obtain ...

Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this stu...

: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE )

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

Testosterone Replacement in Renal Failure

The purpose of this trial is to evaluate the effect of testosterone replacement in men with renal failure (on dialysis) who also have low testosterone. Specifically, we will assess the cha...

Companies [1577 Associated Companies listed on BioPortfolio]

Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL

Lipocine, Inc.

Lipocine Inc. is a specialty pharmaceutical company developing innovative products for use in men’s and women’s health using its proprietary drug delivery technologies. ...

CarrollDrugs.Com - The online department of Taneytown Pharmacy

Carroll Drugs offers full line pharmacy services and features hormone replacement therapy with local and national delivery. In addition to traditional prescriptions, we compound medications specific ...

Executive Committee of Beautiful Study

Swiss Academy ofMedical Sciences (SAMS)

The highest organ of the SAMS is the Supreme Council, which is made up of – besides honorary members, associate members and corresponding members - representatives of the Swiss medical and veterinar...

More Information about "Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL" on BioPortfolio

We have published hundreds of Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL news stories on BioPortfolio along with dozens of Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL Clinical Trials and PubMed Articles about Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL Companies in our database. You can also find out about relevant Plaintiffs' Executive Committee on the Testosterone Replacement Therapy MDL Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record